Versant Capital Management Inc Boosts Holdings in Relx Plc (NYSE:RELX)

Versant Capital Management Inc raised its stake in Relx Plc (NYSE:RELX - Free Report) by 1,382.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,172 shares of the technology company's stock after acquiring an additional 9,486 shares during the period. Versant Capital Management Inc's holdings in Relx were worth $513,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Perigon Wealth Management LLC grew its position in Relx by 11.3% in the 4th quarter. Perigon Wealth Management LLC now owns 6,972 shares of the technology company's stock worth $334,000 after purchasing an additional 707 shares during the period. Hamilton Point Investment Advisors LLC grew its holdings in Relx by 1.9% during the fourth quarter. Hamilton Point Investment Advisors LLC now owns 158,602 shares of the technology company's stock valued at $7,204,000 after purchasing an additional 2,997 shares during the period. Caprock Group LLC grew its stake in shares of Relx by 4.1% during the 4th quarter. Caprock Group LLC now owns 37,019 shares of the technology company's stock valued at $1,681,000 after acquiring an additional 1,460 shares during the period. Journey Strategic Wealth LLC increased its stake in shares of Relx by 54.7% in the fourth quarter. Journey Strategic Wealth LLC now owns 8,814 shares of the technology company's stock worth $400,000 after purchasing an additional 3,117 shares in the last quarter. Finally, CENTRAL TRUST Co raised its position in shares of Relx by 1,290.2% during the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock valued at $26,000 after purchasing an additional 529 shares during the period. 15.02% of the stock is currently owned by institutional investors.

Relx Trading Up 0.9%

Shares of RELX traded up $0.47 during trading hours on Wednesday, reaching $54.53. 1,162,785 shares of the company traded hands, compared to its average volume of 724,120. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. The firm has a market cap of $100.66 billion, a price-to-earnings ratio of 29.32, a PEG ratio of 2.73 and a beta of 0.86. The stock's fifty day moving average price is $52.45 and its 200 day moving average price is $49.57. Relx Plc has a 12-month low of $43.45 and a 12-month high of $56.33.

Wall Street Analyst Weigh In

Several analysts recently issued reports on RELX shares. Morgan Stanley reiterated an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. The Goldman Sachs Group initiated coverage on shares of Relx in a research report on Wednesday, March 26th. They set a "buy" rating on the stock. Barclays raised shares of Relx from an "equal weight" rating to an "overweight" rating in a research note on Friday, March 14th. Finally, Wall Street Zen downgraded shares of Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Relx has an average rating of "Buy".

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.